(2026). Six‐month real‐world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementia. Alzheimer's & Dementia: Translational Research & Clinical Interventions.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Six‐month Real‐world Amyloid PET Outcomes After Lecanemab: Greater Amyloid Reduction at the MCI Stage than in Dementia."
Alzheimer's & Dementia: Translational Research & Clinical Interventions 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Six‐month Real‐world Amyloid PET Outcomes After Lecanemab: Greater Amyloid Reduction at the MCI Stage than in Dementia."
Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.